We are live on ! Find out more
DPLO

DIPLOMAT PHARMACY, INC.
DPLO

Delisted

DPLO was delisted on the 7th of February, 2020.

175 hedge funds and large institutions have $706M invested in DIPLOMAT PHARMACY, INC. in 2017 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 75 increasing their positions, 37 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

175% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 12

103% more repeat investments, than reductions

Existing positions increased: 75 | Existing positions reduced: 37

32% more call options, than puts

Call options by funds: $1.89M | Put options by funds: $1.44M

13% more funds holding

Funds holding: 155175 (+20)

9% less capital invested

Capital invested by funds: $778M → $706M (-$71.2M)

Holders
175
Holders Change
+20
Holders Change %
+12.9%
% of All Funds
4.36%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
33
Increased
75
Reduced
37
Closed
12
Calls
$1.89M
Puts
$1.44M
Net Calls
+$453K
Net Calls Change
+$539K
Name Holding Trade Value Shares
Change
Change in
Stake
TCIM
26
TIAA CREF Investment Management
New York
$5.63M +$122K +7,348 +2%
Dimensional Fund Advisors
27
Dimensional Fund Advisors
Texas
$5.3M +$911K +54,661 +18%
Principal Financial Group
28
Principal Financial Group
Iowa
$4.92M +$39.5K +2,372 +0.7%
Morgan Stanley
29
Morgan Stanley
New York
$4.69M +$2.74M +164,523 +108%
TA
30
Teachers Advisors
New York
$4.4M +$295K +17,711 +6%
JP Morgan Chase
31
JP Morgan Chase
New York
$4.18M +$4.59M +275,387 +3,806%
Deutsche Bank
32
Deutsche Bank
Germany
$4.15M -$1.53M -91,599 -25%
State of Wisconsin Investment Board
33
State of Wisconsin Investment Board
Wisconsin
$4.11M +$417K +25,000 +10%
Ameriprise
34
Ameriprise
Minnesota
$4.04M +$736K +44,135 +19%
CAM
35
Cortina Asset Management
Wisconsin
$3.75M +$4.22M +253,096 New
Charles Schwab
36
Charles Schwab
California
$3.4M +$1.1M +66,244 +40%
CCMH
37
Cornerstone Capital Management Holdings
New York
$3.15M +$3.55M +213,000 New
Citigroup
38
Citigroup
New York
$2.99M +$1.65M +98,914 +96%
O
39
OppenheimerFunds
New York
$2.7M -$489K -29,359 -14%
Invesco
40
Invesco
Georgia
$2.62M +$48.6K +2,914 +2%
T. Rowe Price Associates
41
T. Rowe Price Associates
Maryland
$2.19M -$21M -1,262,022 -90%
OAM
42
Oxford Asset Management
United Kingdom
$2.16M +$2.43M +145,899 New
GC
43
Guggenheim Capital
Illinois
$2.13M -$847K -50,794 -26%
Goldman Sachs
44
Goldman Sachs
New York
$1.98M +$306K +18,348 +16%
Barclays
45
Barclays
United Kingdom
$1.97M +$1.36M +81,525 +158%
SGH
46
Sivik Global Healthcare
Connecticut
$1.78M +$317K +19,000 +19%
PP
47
PDT Partners
New York
$1.64M +$1.85M +110,787 New
NFA
48
Nationwide Fund Advisors
Ohio
$1.58M +$1.27M +76,376 +254%
HHC
49
Hutchin Hill Capital
New York
$1.55M +$1.75M +105,100 New
Kayne Anderson Rudnick Investment Management
50
Kayne Anderson Rudnick Investment Management
California
$1.43M +$1.06M +63,787 +195%

DPLO Hedge Fund Activity: Q2 2017 in Review

175 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in DIPLOMAT PHARMACY, INC. (DPLO) for Q2 2017, worth a combined $706M — down 9.2% from $778M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new DPLO positions and 12 closed out — a net gain of 21 holders — while 75 added to existing stakes and 37 trimmed.

The largest buyer was Janus Henderson Group, opening a new position worth an estimated $76M. The largest seller was T. Rowe Price Associates, cutting an estimated $21M.

  • 175 institutional investors held DIPLOMAT PHARMACY, INC. (DPLO) as of Q2 2017, up from 155 in Q1 2017.
  • Funds reported $706M of DIPLOMAT PHARMACY, INC. stock for Q2 2017, down 9.2% quarter-over-quarter.
  • 33 funds opened new DIPLOMAT PHARMACY, INC. positions in Q2 2017 and 12 closed out, a net change of +21 holders.
  • The largest DIPLOMAT PHARMACY, INC. buyer in Q2 2017 was Janus Henderson Group, an estimated $76M added.
  • The largest DIPLOMAT PHARMACY, INC. seller in Q2 2017 was T. Rowe Price Associates, an estimated $21M sold.

Based on aggregated 13F filings for Q2 2017.